Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.
Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
A key study used in securing FDA approval for Wegovy as a lifetime medication for weight loss was based on patients using the ...
A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined ...
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...
Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...
CORPUS CHRISTI, Texas — While weight-loss medications are not new to the scene ... and from similar organizations and other countries to get it approved to be used in children." That drug ...
F ROM LOS ANGELES to London, weight-loss drugs such as Ozempic are reshaping culture as much as waistlines. Some ...
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...